Self-Administered Parenteral Market Report: Trends, Forecast and Competitive Analysis to 2030
2 – 3 business days after placing order
Self-Administered Parenteral Trends and Forecast
The future of the global self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets. The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Self-Administered Parenteral by Segment
The study includes a forecast for the global self-administered parenteral by product type, usage, distribution channel, application, and region.
Self-Administered Parenteral Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies self-administered parenteral companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the self-administered parenteral companies profiled in this report include-
Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.
Within this market, pain management is expected to witness the highest growth over the forecast period.
APAC is expected to witness the highest growth over the forecast period.
Features of the Global Self-Administered Parenteral Market
Market Size Estimates: Self-administered parenteral market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Self-administered parenteral market size by various segments, such as by product type, usage, distribution channel, application, and region in terms of value ($B).
Regional Analysis: Self-administered parenteral market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, usages, distribution channels, applications, and regions for the self-administered parenteral market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the self-administered parenteral market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for self-administered parenteral market?
Answer: The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the self-administered parenteral market?
Answer: The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.
Q3. What are the major segments for self-administered parenteral market?
Answer: The future of the self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets.
Q4. Who are the key self-administered parenteral market companies?
Answer: Some of the key self-administered parenteral companies are as follows:
Answer: Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.
Q6. In self-administered parenteral market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the self-administered parenteral market by product type (pre-filled syringes, auto injectors, pen injectors, and others), usage (disposable and reusable), distribution channel (hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, and others), application (cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Self-Administered Parenteral Market, Self-Administered Parenteral Market Size, Self-Administered Parenteral Market Growth, Self-Administered Parenteral Market Analysis, Self-Administered Parenteral Market Report, Self-Administered Parenteral Market Share, Self-Administered Parenteral Market Trends, Self-Administered Parenteral Market Forecast, Self-Administered Parenteral Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Self-Administered Parenteral Trends and Forecast
The future of the global self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets. The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Self-Administered Parenteral by Segment
The study includes a forecast for the global self-administered parenteral by product type, usage, distribution channel, application, and region.
Self-Administered Parenteral Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
- Pre-Filled Syringes
- Auto injectors
- Pen Injectors
- Others
- Disposable
- Reusable
- Hospital Pharmacies
- Online Pharmacies
- Home Healthcare Providers
- Specialty Clinics
- Others
- Cardiovascular Diseases
- Diabetes
- Osteoporosis
- Pain Management
- Hormone Replacement
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies self-administered parenteral companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the self-administered parenteral companies profiled in this report include-
- Becton, Dickinson and Company
- scPharmaceuticals
- Harro Hцfliger
- Owen Mumford
- Haselmeier
- Stevanato Group
- Ypsomed AG
- Solteam Group
- AstraZeneca
- Enable Injections
Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.
Within this market, pain management is expected to witness the highest growth over the forecast period.
APAC is expected to witness the highest growth over the forecast period.
Features of the Global Self-Administered Parenteral Market
Market Size Estimates: Self-administered parenteral market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Self-administered parenteral market size by various segments, such as by product type, usage, distribution channel, application, and region in terms of value ($B).
Regional Analysis: Self-administered parenteral market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, usages, distribution channels, applications, and regions for the self-administered parenteral market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the self-administered parenteral market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for self-administered parenteral market?
Answer: The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the self-administered parenteral market?
Answer: The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.
Q3. What are the major segments for self-administered parenteral market?
Answer: The future of the self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets.
Q4. Who are the key self-administered parenteral market companies?
Answer: Some of the key self-administered parenteral companies are as follows:
- Becton, Dickinson and Company
- scPharmaceuticals
- Harro Hцfliger
- Owen Mumford
- Haselmeier
- Stevanato Group
- Ypsomed AG
- Solteam Group
- AstraZeneca
- Enable Injections
Answer: Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.
Q6. In self-administered parenteral market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the self-administered parenteral market by product type (pre-filled syringes, auto injectors, pen injectors, and others), usage (disposable and reusable), distribution channel (hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, and others), application (cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Self-Administered Parenteral Market, Self-Administered Parenteral Market Size, Self-Administered Parenteral Market Growth, Self-Administered Parenteral Market Analysis, Self-Administered Parenteral Market Report, Self-Administered Parenteral Market Share, Self-Administered Parenteral Market Trends, Self-Administered Parenteral Market Forecast, Self-Administered Parenteral Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL SELF-ADMINISTERED PARENTERAL MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Self-Administered Parenteral Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Self-Administered Parenteral Market by Product Type
3.3.1: Pre-Filled Syringes
3.3.2: Auto injectors
3.3.3: Pen Injectors
3.3.4: Others
3.4: Global Self-Administered Parenteral Market by Usage
3.4.1: Disposable
3.4.2: Reusable
3.5: Global Self-Administered Parenteral Market by Distribution Channel
3.5.1: Hospital Pharmacies
3.5.2: Online Pharmacies
3.5.3: Home Healthcare Providers
3.5.4: Specialty Clinics
3.5.5: Others
3.6: Global Self-Administered Parenteral Market by Application
3.6.1: Cardiovascular Diseases
3.6.2: Diabetes
3.6.3: Osteoporosis
3.6.4: Pain Management
3.6.5: Hormone Replacement
3.6.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Self-Administered Parenteral Market by Region
4.2: North American Self-Administered Parenteral Market
4.2.1: North American Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
4.2.2: North American Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
4.3: European Self-Administered Parenteral Market
4.3.1: European Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
4.3.2: European Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
4.4: APAC Self-Administered Parenteral Market
4.4.1: APAC Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
4.4.2: APAC Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
4.5: ROW Self-Administered Parenteral Market
4.5.1: ROW Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
4.5.2: ROW Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Self-Administered Parenteral Market by Product Type
6.1.2: Growth Opportunities for the Global Self-Administered Parenteral Market by Usage
6.1.3: Growth Opportunities for the Global Self-Administered Parenteral Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Self-Administered Parenteral Market by Application
6.1.5: Growth Opportunities for the Global Self-Administered Parenteral Market by Region
6.2: Emerging Trends in the Global Self-Administered Parenteral Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Self-Administered Parenteral Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Self-Administered Parenteral Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Becton, Dickinson and Company
7.2: scPharmaceuticals
7.3: Harro Hцfliger
7.4: Owen Mumford
7.5: Haselmeier
7.6: Stevanato Group
7.7: Ypsomed AG
7.8: Solteam Group
7.9: AstraZeneca
7.10: Enable Injections
2. GLOBAL SELF-ADMINISTERED PARENTERAL MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Self-Administered Parenteral Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Self-Administered Parenteral Market by Product Type
3.3.1: Pre-Filled Syringes
3.3.2: Auto injectors
3.3.3: Pen Injectors
3.3.4: Others
3.4: Global Self-Administered Parenteral Market by Usage
3.4.1: Disposable
3.4.2: Reusable
3.5: Global Self-Administered Parenteral Market by Distribution Channel
3.5.1: Hospital Pharmacies
3.5.2: Online Pharmacies
3.5.3: Home Healthcare Providers
3.5.4: Specialty Clinics
3.5.5: Others
3.6: Global Self-Administered Parenteral Market by Application
3.6.1: Cardiovascular Diseases
3.6.2: Diabetes
3.6.3: Osteoporosis
3.6.4: Pain Management
3.6.5: Hormone Replacement
3.6.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Self-Administered Parenteral Market by Region
4.2: North American Self-Administered Parenteral Market
4.2.1: North American Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
4.2.2: North American Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
4.3: European Self-Administered Parenteral Market
4.3.1: European Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
4.3.2: European Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
4.4: APAC Self-Administered Parenteral Market
4.4.1: APAC Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
4.4.2: APAC Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
4.5: ROW Self-Administered Parenteral Market
4.5.1: ROW Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
4.5.2: ROW Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Self-Administered Parenteral Market by Product Type
6.1.2: Growth Opportunities for the Global Self-Administered Parenteral Market by Usage
6.1.3: Growth Opportunities for the Global Self-Administered Parenteral Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Self-Administered Parenteral Market by Application
6.1.5: Growth Opportunities for the Global Self-Administered Parenteral Market by Region
6.2: Emerging Trends in the Global Self-Administered Parenteral Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Self-Administered Parenteral Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Self-Administered Parenteral Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Becton, Dickinson and Company
7.2: scPharmaceuticals
7.3: Harro Hцfliger
7.4: Owen Mumford
7.5: Haselmeier
7.6: Stevanato Group
7.7: Ypsomed AG
7.8: Solteam Group
7.9: AstraZeneca
7.10: Enable Injections
